Navigation Links
Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
Date:9/8/2009

DURHAM, N.C., Sept. 8 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) announced that it has formally notified Vatea Fund of the company's achievement of a milestone under the Securities Purchase Agreement dated June 8, 2009, as amended September 1, 2009. The milestone is a Clinical Trial for Oxycyte in Traumatic Brain Injury Approved by Swissmedic.

With the achievement of the milestone, the agreement calls for Vatea Fund to purchase 24 million shares of Oxygen Biotherapeutics stock from the company for $6 million with the transaction to close no later than December 10, 2009.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
2. Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
3. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
6. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
9. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
10. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
11. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... --Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... the 27th Annual ROTH Conference on March 10, 2015 ... California . To learn more about the ROTH ... live webcast of the presentation will be available on ...
(Date:3/4/2015)... 2015  Students from Indiana University School of Medicine ... are discovered. Through a partnership with Lilly ... IU School of Medicine are learning about drug development ... different and important roles in bringing new and innovative ... educator, scientific investigator, and health system administrator, I recognize ...
(Date:3/4/2015)... LAKE CITY , March 4, 2015  ECR ... VAR ) is showcasing a full spectrum of ... improve image quality, reduce costs, and enable greater patient ... cone-beam CT imaging systems.  These solutions are on display ... in Vienna, Austria this week.   ...
Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... American Medical Systems® (AMS) (NASDAQ: AMMD), a ... and female pelvic health, today announced it has received ... Welfare (MHLW) to market and distribute its GreenLight HPS® ... Hyperplasia (BPH), or enlarged prostate, in Japan. ...
... 2011 Misonix, Inc. (NASDAQ: MSON ), ... innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic ... applications, announced today that it will present at the ... 2011 at the Le Parker Meridien Hotel in New ...
Cached Medicine Technology:American Medical Systems' GreenLight HPS® Approved for Use in Japan 2Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011 2
(Date:3/4/2015)... is no stranger to drug addiction. The bustling city has ... from the potential threat of Kratom. In a report by ... Kratom is a “drug of concern.” Although Kratom is legally ... Southeast Asia acts as a stimulant in low doses, yet ... similar to heroin withdrawal, and includes tremors, irritation, anxiety, and ...
(Date:3/4/2015)... SIGVARIS proved innovative when ... first compression therapy collection designed exclusively for men. ... USA is proud to announce the launch of three ... Constructed from a unique, extremely fine synthetic fiber, MIDTOWN ... socks and thigh-highs offer a tailored look that is ...
(Date:3/4/2015)... According to a new report published ... the U.S. suffer from gastroesophageal reflux disease (GERD), more ... to control acid production, but these can have side ... the problem and lead to other uncomfortable digestive conditions. ... the lower esophageal sphincter does not function properly. Anti-reflux ...
(Date:3/4/2015)... 04, 2015 In a small ceremony with ... on their new facility in New Port Richey on February ... new facility will allow the Florida drug detox facility ... drug abuse epidemic through treatment and education. “Due to our ... in the United States, we made the decision that expanding ...
(Date:3/4/2015)... 04, 2015 Jeannie Mai, TV personality, fashion ... graces the cover of the print publication. Mai embraces the ... organic when shopping for clothes and personal care products. In ... about her commitment to an organic diet. She mentions, “Having ... only in gymnastics, but also now as I’m a full ...
Breaking Medicine News(10 mins):Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... MINNEAPOLIS / ST. PAUL Minn. (October 28, 2010) ... Medical Center researchers have discovered a correlation between increased ... and the debilitating, involuntary flashbacks triggered by post traumatic ... PTSD through concrete evidence of neural activity, its impact ...
... HealthDay Reporter , THURSDAY, Oct. 28 (HealthDay ... green tea might help protect women from breast cancer, ... conclusion. "We found no overall association between green ... Japanese women who have habitually drunk green tea," said ...
... , WEDNESDAY, Oct. 27 (HealthDay News) -- Children ... increased risk for obesity in adulthood, a new study ... the symptoms of ADHD -- such as inattention, hyperactivity ... obese, according to researchers from Duke University Medical Center, ...
... , WEDNESDAY, Oct. 27 (HealthDay News) The ... are associated with heightened activity on the right side ... research that included 80 people with PTSD (many of ... and 284 people without the condition, researchers used a ...
... , BOSTON--A new oral drug caused dramatic shrinkage of a ... by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute ... England Journal of Medicine . A second patient who ... mutant protein, called ALK (named for the first disease in ...
... A comprehensive review of national opinion polls, including newly released ... for a Democratic congressional candidate in 2010 and those who ... district hold starkly different views of what they want the ... between Democratic and Republican leaders in Congress on this issue. ...
Cached Medicine News:Health News:U of M researchers identify possible key to treating, understanding post-traumatic stress disorder 2Health News:Study Finds Green Tea Offers No Protection From Breast Cancer 2Health News:Children with ADHD Symptoms at Higher Risk of Obesity 2Health News:PTSD Linked to 'Hyperactivity' in Right Brain 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 3Health News:Prospective voters and the new health care law 2
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
An ideal choice for film photography. The new TRC-50FXC provides 35mm color and Polaroid capability....
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
Medicine Products: